NeuroBo Pharmaceuticals Inc. logo

NRBO

NeuroBo Pharmaceuticals Inc. · NASDAQ

Website

NeuroBo Pharmaceuticals Inc. (NRBO) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for NRBO in the last 30 days. The most recent was published Dec 2, 2024.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.

Latest news

25 items

NRBO FAQ

7 questions
  • What does NeuroBo Pharmaceuticals Inc. do?
    NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an acute indication for COVID-19. NeuroBo...
  • What is the latest news on NRBO?
    Quantisnow has not tracked any new filings, ratings or press releases for NRBO in the last 30 days. The most recent wire item was published on December 2, 2024.
  • Where does NRBO stock trade?
    NeuroBo Pharmaceuticals Inc. (NRBO) is listed on NASDAQ.
  • What sector and industry is NRBO in?
    NeuroBo Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did NeuroBo Pharmaceuticals Inc. go public?
    NeuroBo Pharmaceuticals Inc. (NRBO) completed its IPO in 2016.
  • What companies are similar to NRBO?
    Notable peers in the same industry include MRK (Merck & Company Inc.), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S), ABT (Abbott Laboratories), JNJ (Johnson & Johnson). Compare NRBO side-by-side with any of them on Quantisnow.
  • How can I track NRBO on Quantisnow?
    Quantisnow aggregates NeuroBo Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NRBO to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change